Royal Bank of Canada Initiates Coverage on Aardvark Therapeutics (NASDAQ:AARD)
Investment analysts at Royal Bank of Canada assumed coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) in a research note issued on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $21.00 price target on the stock. Royal Bank of Canada’s target price points to a potential upside of […]
Investment analysts at Royal Bank of Canada assumed coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) in a research note issued on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $21.00 price target on the stock. Royal Bank of Canada’s target price points to a potential upside of […]
